Press Releases

NEW YORK --(BUSINESS WIRE)-- Retrophin, Inc. (OTCQB: RTRX) today announced that it has elected Cornelius ("Neal") E. Golding to its Board of Directors, effective October 1, 2013 . Mr. Golding will also serve as Chairman of the Audit Committee. His appointment brings the Company's Board to four

SAN DIEGO , Oct. 06, 2016 (GLOBE NEWSWIRE) -- Retrophin, Inc. (Nasdaq:RTRX) today announced Alvin Shih , M.D., will be stepping down from his position as executive vice president and head of research and development to become chief executive officer of a start-up biotechnology company. Dr.

NEW YORK --(BUSINESS WIRE)-- Retrophin, Inc. (OTCQB:RTRX) today announced that it has appointed Jeffrey Paley , MD to its Board of Directors, effective November 15, 2013 . This latest appointment brings the Company's Board to five members. Commenting on today's news, Martin Shkreli , Founder,

Grant program established with gift from Retrophin Washington, DC and San Diego, May 20, 2019 --The National Organization for Rare Disorders (NORD) Ⓡ , the leading independent nonprofit organization representing the 25-30 million Americans living with rare diseases, has launched the Rare Caregiver

Proceeds of $245 million over two years SAN DIEGO --(BUSINESS WIRE)-- Retrophin, Inc. (NASDAQ:RTRX) today announced an agreement to sell its Rare Pediatric Disease Priority Review Voucher ("Pediatric PRV") to Sanofi (NYSE:SNY). Retrophin received the Pediatric PRV when Cholbam™ was approved